Home | Business News | Browse by Publication | P | PR Newswire

Insmed to Appeal Delisting Notification From Nasdaq.

Publication: PR Newswire
Publication Date: 26-DEC-07
Format: Online
Delivery: Immediate Online Access

Article Excerpt
RICHMOND, Va., Dec. 26 /PRNewswire-FirstCall/ -- Insmed Inc. , a developer of follow-on biologics and biopharmaceuticals, today announced that it has requested a hearing before a Nasdaq Listing Qualifications Panel to appeal an earlier Staff Determination to delist the Company's common stock from the Nasdaq Global Market.

Insmed received a letter from the Nasdaq Stock Market ("Nasdaq") on December 20, 2007 indicating that the Company has failed to regain compliance with Nasdaq's minimum bid price requirement of $1.00 per share for continued listing of...



More articles from PR Newswire
Statement Regarding 'Courtney Prince v. Madison Square Garden, L.P., e..., December 26, 2007
Metalfrio Informs that it has Entered into a Share Purchase and Shareh..., December 26, 2007
Rose Parade(R) Introduces First-Ever Audio Tour of Floats at Post Para..., December 26, 2007
Tralliance Announced Successful Implementation of New Policies., December 26, 2007
Capital Bank Corporation Announces Write-Down and Reorganization Charg..., December 26, 2007

Looking for additional articles?
Search our database of over 3 million articles.

Looking for more in-depth information on this industry?
Search our complete database of Industry & Market reports by text, subject, publication name or publication date.

About Goliath
Whether you're looking for sales prospects, competitive information, company analysis or best practices in managing your organization, Goliath can help you meet your business needs.

Our extensive business information databases empower business professionals with both the breadth and depth of credible, authoritative information they need to support their business goals. Whether it be strategic planning, sales prospecting, company research or defining management best practices - Goliath is your leading source for accurate information.